Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Investigation

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI44907PMID 21245575PMCID PMC3026737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice.

  2009influential reference
• Embryonic Stem Cells and Their Differentiated Derivatives Have a Fragile Immune Privilege but Still Represent Novel Targets of Immune Attack

  2008cited by this paper
• Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero

  2008cited by this paper
• Donor major histocompatibility complex class I expression determines the outcome of prenatal transplantation.

  2008cited by this paper
• In utero hematopoietic stem cell transplantation: progress toward clinical application.

  2008cited by this paper
• Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.

  2008cited by this paper
• Tolerance Induction or Sensitization in Mice Exposed to Noninherited Maternal Antigens (NIMA)

  2008cited by this paper
• Immunobiology of exposure to non-inherited maternal antigens.

  2007cited by this paper
• Evidence for an immune barrier after in utero hematopoietic-cell transplantation.

  2007influential reference
• The human-sheep chimeras as a model for human stem cell mobilization and evaluation of hematopoietic grafts' potential.

  2007cited by this paper
• Bi-directional cell trafficking between mother and fetus in mouse placenta.

  2007cited by this paper
• The effect of noninherited maternal antigens in allogeneic transplantation.

  2005cited by this paper
• High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery.

  2005cited by this paper
• In Utero Bone Marrow Transplantation Induces Kidney Allograft Tolerance Across a Full Major Histocompatibility Complex Barrier in Swine

  2005cited by this paper
• Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-twin transfusion syndrome.

  2005cited by this paper
• Influence of Maternal-Fetal Histocompatibility and MHC Zygosity on Maternal Microchimerism1

  2005cited by this paper
• Microchimerism: an investigative frontier in autoimmunity and transplantation.

  2004cited by this paper
• Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy.

  2003cited by this paper
• Chimerism of Murine Fetal Bone Marrow by Maternal Cells Occurs in Late Gestation and Persists into Adulthood

  2003cited by this paper
• Fetal cell microchimerism: helpful or harmful to the parous woman?

  2003cited by this paper
• Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

  2002cited by this paper
• Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients.

  2002cited by this paper
• Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.

  2002cited by this paper
• Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1

  2001influential reference
• Two independent pathways of maternal cell transmission to offspring: through placenta during pregnancy and by breast‐feeding after birth

  2000cited by this paper
• Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

  2000cited by this paper
• Microchimerism of maternal origin persists into adult life.

  1999cited by this paper
• The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors.

  1999cited by this paper
• In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy.

  1999cited by this paper
• In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers.

  1999cited by this paper
• Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer.

  1998cited by this paper
• The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors.

  1998cited by this paper
• Maternal plasma fetal DNA as a marker for preterm labour.

  1998cited by this paper
• Microchimerism and tolerance after in utero bone marrow transplantation in mice.

  1998cited by this paper
• In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI).

  1997cited by this paper
• Immunological tolerance following stem cell transplantation in human fetuses in utero.

  1997cited by this paper
• Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.

  1996cited by this paper
• Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow.

  1996cited by this paper
• Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.

  1996cited by this paper
• Maternal cells are widely distributed in murine fetuses in utero.

  1996cited by this paper
• Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep.

  1994cited by this paper
• THE CORRELATION OF PROLONGED SURVIVAL OF MATERNAL SKIN GRAFTS WITH THE PRESENCE OF NATURALLY TRANSFERRED MATERNAL T CELLS

  1993cited by this paper
• Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus.

  1993cited by this paper
• Effect of natural killer cell depletion on long-term multilineage allogeneic bone marrow engraftment.

  1993cited by this paper
• Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.

  1992cited by this paper
• Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages

  1992cited by this paper
• RAG-1-deficient mice have no mature B and T lymphocytes.

  1992cited by this paper
• ‘Actively Acquired Tolerance’ of Foreign Cells

  1953influential reference
• IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS.

  1945cited by this paper

• The when, what, and where of naturally-acquired microchimerism

  2025cites this paper
• Hemophilia A: An Ideal Disease for Prenatal Therapy.

  2025cites this paper
• Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early‐Onset Lysosomal Storage Diseases

  2025cites this paper
• Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation

  2024cites this paper
• In utero hematopoietic stem cell transplantation for Fanconi anemia

  2024cites this paper
• Transamniotic Fetal Administration of Genetically Modified Hematopoietic Stem Cells Carrying a Human Transgene in a Syngeneic Rat Model

  2023cites this paper
• Establishment of the fetal-maternal interface: developmental events in human implantation and placentation

  2023cites this paper
• Maternal dendritic cells influence fetal allograft response following murine in-utero hematopoietic stem cell transplantation

  2023cites this paper
• Pregnancy‐induced transfer of pathogen‐specific T cells from mother to fetus in mice

  2023cites this paper
• Pregnancy-induced maternal microchimerism shapes neurodevelopment and behavior in mice

  2022cites this paper
• Fetal therapies and trials for lysosomal storage diseases: a survey of attitudes of parents and patients

  2022cites this paper
• Associations between Allergic and Autoimmune Diseases with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder within Families: A Population-Based Cohort Study

  2022cites this paper
• In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death

  2022cites this paper
• Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders

  2022cites this paper
• Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI‐FDA Meeting)

  2022cites this paper
• Immunological Consequences of In Utero Exposure to Foreign Antigens

  2021influential citation
• Advances in the management of α-thalassemia major: reasons to be optimistic.

  2021cites this paper
• The Future of Fetal Surgery.

  2021cites this paper
• Prenatal Gene Therapy

  2021cites this paper
• In Utero Stem Cell Transplantation, Enzyme Replacement, and Gene Therapy

  2021cites this paper
• Maternal microchimerism and cell‐mediated immune‐modulation enhance engraftment following semi‐allogenic intrauterine transplantation

  2021cites this paper
• In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System

  2021cites this paper
• Gene and Stem Cell Therapies for Fetal Care: A Review.

  2020cites this paper
• A narrative review of in utero gene therapy: advances, challenges, and future considerations

  2020cites this paper
• Forever Connected: The Lifelong Biological Consequences of Fetomaternal and Maternofetal Microchimerism.

  2020cites this paper
• The relative abundance of monocyte subsets determines susceptibility to perinatal hepatic inflammation.

  2020cites this paper
• Engraftment potential of maternal adipose-derived stem cells for fetal transplantation

  2020cites this paper
• Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with mucopolysaccharidosis type VII

  2020influential citation
• Tissue engineering and transplantation in the fetus

  2020cites this paper
• Ly6cLo non-classical monocytes promote resolution of rhesus rotavirus-mediated perinatal hepatic inflammation

  2020cites this paper
• In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long‐Term Hematopoietic Engraftment

  2019cites this paper
• Prenatal Cell- and Gene-Based Therapies for Regenerative Medicine

  2019cites this paper
• In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI Techniques

  2019cites this paper
• Fetoscopic versus Ultrasound-Guided Intravascular Delivery of Maternal Bone Marrow Cells in Fetal Macaques: A Technical Model for Intrauterine Haemopoietic Cell Transplantation

  2019cites this paper
• Mechanistic Insights into Factor VIII Immune Tolerance Induction via Prenatal Cell Therapy in Hemophilia A

  2019cites this paper
• Donor-Cell Engineering with GSK3 Inhibitor-Loaded Nanoparticles Enhances Engraftment Following in Utero Transplantation.

  2019cites this paper
• A Simple Approach to Increase Donor Hematopoeitic Stem Cell Dose and Improve Engraftment in the Murine Model of Allogeneic In Utero Hematopoietic Cell Transplantation.

  2019cites this paper
• In Utero Hematopoietic Cell Transplantation: Past Clinical Experience and Future Clinical Trials

  2018cites this paper
• Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector–mediated intrauterine gene transfer in early-gestation fetal macaques

  2018cites this paper
• Alloreactive fetal T cells promote uterine contractility in preterm labor via IFN-γ and TNF-α

  2018cites this paper
• Preclinical Canine Model of Graft-versus-Host Disease after In Utero Hematopoietic Cell Transplantation.

  2018cites this paper
• Depletion of murine fetal hematopoietic stem cells with c-Kit receptor and CD47 blockade improves neonatal engraftment.

  2018cites this paper
• Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells.

  2018cites this paper
• Inherited nongenetic influences on the gut microbiome and immune system

  2018cites this paper
• Maternal and Fetal Immune Response to In Utero Stem Cell Transplantation

  2018cites this paper
• A review of application of stem cell therapy in the management of congenital heart disease

  2018cites this paper
• A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model

  2018cites this paper
• Isolation and Characteristics of Mesenchymal Stromal Cells from Different Parts of Placenta

  2017cites this paper
• Immunological implications of pregnancy-induced microchimerism

  2017cites this paper
• Fetal stem cell and gene therapy.

  2017cites this paper
• Chapter 2 Feto-Maternal Cell Trafficking and Labor

  2017cites this paper
• HIV-1 at the placenta: immune correlates of protection and infection

  2016cites this paper
• In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application

  2016cites this paper
• Dendritic Cells in the Immune System—History, Lineages, Tissues, Tolerance, and Immunity

  2016cites this paper
• First steps to define murine amniotic fluid stem cell microenvironment

  2016cites this paper
• Monitoring of Venus transgenic cell migration during pregnancy in non-transgenic rabbits

  2016cites this paper
• Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation

  2016cites this paper
• Fetal Surgical conditions and the unraveling of maternal-fetal tolerance.

  2016cites this paper
• Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature

  2016cites this paper
• In utero stem cell transplantation and gene therapy: Recent progress and the potential for clinical application.

  2016cites this paper
• The Intravenous Route of Injection Optimizes Engraftment and Survival in the Murine Model of In Utero Hematopoietic Cell Transplantation.

  2016cites this paper
• Feto-Maternal Cell Trafficking and Labor

  2016cites this paper
• Cytokines and Myometrial Signalling in Human Labour

  2016cites this paper
• Microquimerismos en la enfermedad de Alzheimer y la demencia frontotemporal

  2015cites this paper
• Engineering muscle tissue for the fetus: getting ready for a strong life

  2015cites this paper
• NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation

  2015cites this paper
• Engraftment of mouse amniotic fluid-derived progenitor cells after in utero transplantation in mice.

  2015cites this paper
• Maternal microchimerism: lessons learned from murine models.

  2015influential citation
• Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin-positive compartments that are accessible to broadly neutralizing antibodies

  2015cites this paper
• Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero

  2015cites this paper
• Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.

  2014cites this paper
• Amniotic fluid stem cells for minimally invasive prenatal cell therapy

  2014cites this paper
• Maternal immune recognition of the semi-allogeneic fetus during fetal intervention in mice

  2014cites this paper
• Can we fix it? Evaluating the potential of placental stem cells for the treatment of pregnancy disorders.

  2014cites this paper
• Lead to Immune-Mediated Fetal Demise Can Awareness of the Foreign Conceptus and Fetal Intervention Increases Maternal T Cell

  2014cites this paper
• Placental drug delivery for treatment of congenital hematopoietic disorders.

  2014cites this paper
• Hemophilia A: an ideal disease to correct in utero

  2014cites this paper
• Maternal–fetal cellular trafficking: clinical implications and consequences

  2014cites this paper
• Tissue Engineering and Transplantation in the Fetus

  2014cites this paper
• In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice.

  2014cites this paper
• In Utero Stem Cell and Gene Therapy: Current Status and Future Perspectives

  2014cites this paper
• Fetal Intervention Increases Maternal T Cell Awareness of the Foreign Conceptus and Can Lead to Immune-Mediated Fetal Demise

  2014cites this paper
• Selective organ specific inflammation in offspring harbouring microchimerism from strongly alloreactive mothers.

  2014cites this paper
• Advancing the detection of maternal haematopoietic microchimeric cells in fetal immune organs in mice by flow cytometry

  2014cites this paper
• In utero hematopoietic cell transplantation for hemoglobinopathies

  2014cites this paper
• Temporal definition of haematopoietic stem cell niches in a large animal model of in utero stem cell transplantation

  2014cites this paper
• Engineering tissue for the fetus: stem cells and matrix signalling.

  2014cites this paper
• In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants

  2014cites this paper
• Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT)

  2014cites this paper
• Increased maternal T cell microchimerism in the allogeneic fetus during LPS-induced preterm labor in mice

  2014cites this paper
• In utero therapy for congenital disorders using amniotic fluid stem cells

  2014cites this paper
• Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.

  2014cites this paper
• Influence of a dual-injection regimen, plerixafor, and CXCR4 on in-utero hematopoietic stem cell transplantation and engraftment using the sheep model

  2014cites this paper
• In utero hematopoietic cell transplantation--recent progress and the potential for clinical application.

  2013cites this paper
• Stem cell and genetic therapies for the fetus.

  2013cites this paper
• Gynecology and Minimally Invasive Therapy

  2013cites this paper
• Biomaterials for Cell Engineering and Regenerative Medicine

  2013cites this paper
• Pathogenesis of Fetal and Neonatal Immune Thrombocytopenia: Role of Anti-Beta3 Integrin Antibodies in Vascular Injury and Angiogenesis

  2013cites this paper
• Clinical implications of maternal-fetal cellular trafficking.

  2013cites this paper
• In utero transplantation: Disparate ramifications.

  2013cites this paper